The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.
作者信息
Namavar F, Severin W P, Stobberingh E, Smeets T, MacLaren D M
机构信息
Department of Clinical Microbiology and Infection Control, University Hospital, Vrije Universiteit, Amsterdam, The Netherlands.
出版信息
J Antimicrob Chemother. 1994 Sep;34(3):415-9. doi: 10.1093/jac/34.3.415.
PMID:7829416
Abstract
摘要
相似文献
1
The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.厌氧菌临床分离株对哌拉西林-他唑巴坦及其他抗菌药物的敏感性。
J Antimicrob Chemother. 1994 Sep;34(3):415-9. doi: 10.1093/jac/34.3.415.
2
Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.哌拉西林/他唑巴坦对厌氧菌的比较药敏谱
J Antimicrob Chemother. 1993 Jan;31 Suppl A:29-38. doi: 10.1093/jac/31.suppl_a.29.
3
Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.新型喹诺酮类药物WIN 57273与哌拉西林加他唑巴坦对厌氧菌的体外比较活性
Antimicrob Agents Chemother. 1990 Sep;34(9):1858-61. doi: 10.1128/AAC.34.9.1858.
4
Increased in vitro activity of ceftriaxone by addition of tazobactam against clinical isolates of anaerobes.
Diagn Microbiol Infect Dis. 1994 Aug;19(4):227-34. doi: 10.1016/0732-8893(94)90036-1.
5
Effect of pH on antibiotics used to treat anaerobic infection.pH值对用于治疗厌氧菌感染的抗生素的影响。
J Antimicrob Chemother. 1992 May;29(5):594-5. doi: 10.1093/jac/29.5.594.
6
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.539株革兰氏阳性和革兰氏阴性厌氧菌对新型药物的敏感性，包括RP59500、比阿培南、曲伐沙星和哌拉西林/他唑巴坦。
J Antimicrob Chemother. 1993 Aug;32(2):223-31. doi: 10.1093/jac/32.2.223.
7
In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):177-81. doi: 10.1007/BF01982195.
8
[Evaluation of in vitro susceptibility of hospital bacterial isolates to piperacillin and tazocin (piperacillin/tazobactam].
Med Dosw Mikrobiol. 1998;50(1-2):41-6.
9
Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.哌拉西林/他唑巴坦对不列颠群岛住院患者分离细菌的体外活性比较的多中心调查。
J Antimicrob Chemother. 1993 Aug;32(2):247-66. doi: 10.1093/jac/32.2.247.
10
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.哌拉西林和他唑巴坦对嗜肺军团菌临床分离株的比较活性
Antimicrob Agents Chemother. 1994 Jan;38(1):144-6. doi: 10.1128/AAC.38.1.144.
引用本文的文献
1
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.哌拉西林/他唑巴坦：其在治疗细菌感染中的应用最新综述
Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017.
Zotero 插件